Last reviewed · How we verify
NCT07398443: MATEY
Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults
NA trial testing Cue Reactivity in Behavioral Economics in 120 participants. Currently enrolling.
30 November 2028
Quick facts
| Lead sponsor | Brown University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 120 |
| Start date | 17 February 2026 |
| Primary completion | 30 November 2028 |
| Estimated completion | 30 November 2028 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cue Reactivity
Conditions studied
- Behavioral Economics — all drugs for Behavioral Economics →
- Cannabis Smoking — all drugs for Cannabis Smoking →
- Tobacco Smoking — all drugs for Tobacco Smoking →
Sponsor
Brown University
Who can join
Adults 18 to 25, any sex, with Behavioral Economics or Cannabis Smoking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The multi session experimental study aims to determine dual use patterns of marijuana and tobacco by assessing the impact of price and availability of marijuana and tobacco using a cross price elasticity of demand task. The study will recruit 120 non-treatment seeking emerging young adults (18-25 years) who smoke marijuana and tobacco.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07398443
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Behavioral Economics
Currently open trials in the same condition.
- NCT06446076 — Feedback Using behaviOral econOmic Theories on STEP countS in Cardiovascular Disease Patients · NA · active not recruiting
- NCT06155292 — Report Cards and Feedback for PCCE · NA · recruiting
Other Brown University trials
Trials by the same sponsor.
- NCT07502872 — TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-g · Phase 2 · not yet recruiting
- NCT07118618 — Probenecid Administration for Alcohol Craving and Consumption · Phase 2 · recruiting
- NCT05901766 — Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment · Phase 4 · not yet recruiting
- NCT06974604 — Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM · Phase 2 · recruiting
- NCT06998069 — Head and Neck Cancer Study Project in the Geriatric Population · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07398443 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brown University
- Last refreshed: 4 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07398443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing